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Summary 
The ability of immature neurons from chick lumbosa- 
cral sympathetic ganglia to proliferate in vitro was 
used to identify factors that affect neurogenesis. Un- 
der serum-free culture conditions, insulin-like growth 
factor I (IGF-I), IGF-II, or insulin caused an increase in 
the proportion of cells that incorporated [3H]thymi- 
dine. In addition, IGFs also stimulated neurite out- 
growth from these immature sympathetic neurons. 
IGF-I and IGF-II mRNA was found to be expressed in 
E7 sympathetic ganglia during the period of neurogen- 
esis. IGF-I was detectable in fibroblasts, whereas IGF-II 
mRNA was expressed by neurons, glia, and fibro- 
blasts. Elimination of endogenous IGFs by neutralizing 
antibodies resulted in a reduction of neuron prolifera- 
tion and neuron number, whereas elevation of IGF lev- 
els by treatment with IGF-I increased sympathetic neu- 
ron proliferation in vivo. These findings suggest an 
important role of IGFs for the development of sympa- 
thetic neurons and imply a general role of IGFs in the 
control of neurogenesis and neurite outgrowth. 
Introduction 
The peripheral nervous system is derived from precursors 
in the neural crest. After crest cell migration and aggrega- 
tion to form primitive ganglia, a defined number of neurons 
is generated by proliferation and differentiation of neuron 
precursor cells. It is widely accepted that neuronal devel- 
opment, from early determination events to the final acqui- 
sition of specialized phenotypic traits, is influenced by en- 
vironmental cues. With the exception of factors controlling 
neuron death (Snider, 1994), the signals involved in these 
interactions between developing precursor cells and their 
environment are largely unknown. In particular, neurogen- 
esis and the signals that control the proliferation of neuron 
progenitor cells are not understood at the molecular level 
in vertebrate systems. There is evidence from experimen- 
tal embryology suggesting that neurogenesis in the CNS 
and PNS is subject to extrinsic control (Rohrer, 1990). The 
persistent survival of neuron progenitors after neurogen- 
esis in peripheral ganglia of chick embryos (Xue et al., 
1985) suggests negative control mechanisms that prevent 
the proliferation of such cells during normal development. 
Similar precursor cells were shown to be present even in 
adult avian (Alvarez-Buylla et al., 1990) and mouse brain 
(Reynolds and Weiss, 1992). Evidence for positive effects 
on neuron proliferation was obtained in the spinal cord 
after grafting notochord (Van Straaten et al., 1989) or em- 
bryonic gut (Rothman et al., 1987) in the vicinity of the 
spinal cord. 
In culture, different growth factors have been shown to 
stimulate the incorporation of [3H]thymidine into neuron 
precursors derived from the CNS. Fibroblast growth factor 
(FGF) and epidermal growth factor (EGF) affected cell cul- 
tures of embryonic rat (Gensburger et al., 1987) and 
mouse brain (Drago et al., 1991), retina (Anchan et al., 
1991), and cerebellum (Gao et al., 1991). Insulin-like 
growth factor I (IGF-I) increased the proportion of thymi- 
dine-labeled neurons in cell cultures of embryonic rat tel- 
encephalon (Lenoir and Honegger, 1983). However, the 
analysis of neurogenesis in these experimental systems 
is complicated by the fact that the proliferating cells are 
undifferentiated and have been identified and quantified 
only after their differentiation to neurons. Thus, an in- 
crease in the number of thymidine-labeled neurons may 
be due to increased survival of precursor cells and/or neu- 
rons, increased proliferation, or differentiation. 
In contrast to other neuronal populations, proliferating 
cells that belong to the neuronal cell lineage can be unam- 
bigously identified in the developing sympathoadrenal 
system. Whereas in other parts of the nervous system 
proliferating neuron progenitors are undifferentiated, cells 
of the sympathoadrenergic cell lineage express differenti- 
ated, adrenergic properties during their proliferation 
phase (Rothman et al, 1978; Rohrer and Thoenen, 1987). 
In addition to these adrenergic markers, neuron-specific 
characteristics are also expressed (Rohrer and Thoenen, 
1987). Embryonic chick and rat sympathoadrenergic cells 
and postnatal rat adrenal chromaffin cells (Lillien and 
Claude, 1985; Stemple et al., 1988; Claude et al., 1988; 
DiCicco-Bloom and Black, 1988; Rohrer and Thoenen, 
1987; Ernsberger et al., 1989b) were previously shown to 
proliferate in vitro. In cultures of rat sympathoadrenal cells, 
stimulation of [3H]thymidine incorporation was described 
for the neurotrophin erve growth factor (NGF; Lillien and 
Claude, 1985; Stemple et al., 1988) and the growth factors 
aFGF, bFGF, EGF, IGF-I, and insulin (Claude et al., 1988; 
Stemple et al., 1988; DiCicco-Bloom and Black, 1988). 
Although these results clearly demonstrate that devel- 
oping sympathoadrenal cells in culture respond to these 
factors, the significance of these findings for normal devel- 
opment remains unclear. 
We have now used immature chick sympathetic neurons 
to identify factors that are able to stimulate neuron prolifer- 
ation both in vitro and in vivo. IGF-I, IGF-II, and insulin 
were found to act as in vitro proliferation factors. We also 
observed a stimulation of [3H]thymidine incorporation into 
sympathetic neurons in vivo in response to IG F-I. A physio- 
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Figure 1. Effect of hlGF-I, hlGF-II, tlGF-I, and 
Insulin on Sympathetic Neuron Proliferation 
The percentage of neurons that incorporate 
[3H]thymidine b tween 24 and 48 hr was deter- 
mined by autoradiography. Cultures were 
maintained under serum-free conditions in the 
presence of different concentrations ofhlGF-I 
(open squares), hlGF-II (open squares with 
dots), tIGF-I (open diamonds), and insulin 
(closed diamonds) as indicated. Data repre- 
sent he mean (_ SD) of at least hree separate 
experiments. 
further evidenced by the finding that IGF-I and IGF-II 
mRNA is present in sympathetic ganglia during neurogen- 
esis. IGF-I mRNA could be detected in ganglion fibro- 
blasts; IGF-II mRNA was observed in all cell types present 
in the ganglion. The importance of endogenous IGFs for 
sympathetic neuron development was underscored by the 
ability of neutralizing anti-IGF-I antibodies to decrease 
neuron proliferation and neuron number in sympathetic 
ganglia. 
Results 
IGF-I, IGF-II, and Insulin Stimulate Sympathetic 
Neuron Proliferation 
Immature chick sympathetic neurons from 7-day-old chick 
embryos proliferate in serum-supplemented media (Roh- 
rer and Thoenen, 1987). Under these culture conditions, 
neuronal proliferation seems to be maximally stimulated, 
as the extent of [3H]thymidine incorporation could not be 
increased by the addition of growth factors (Ernsberger et 
al., 1989b). Thus, to identify factors that affect sympathetic 
neuron proliferation, cells were maintained in a defined 
medium. Under these conditions virtually no thymidine- 
incorporating cells could be detected, but all of the plated 
neurons (106% -+ 7%; n = 4) were alive after 3 days in 
culture. Thus, an increase in the proportion of [3H]thymi- 
dine-incorporating cells reflects increased proliferation 
rather than increased survival. In this way, it was possible 
to demonstrate that sympathetic neurons resume the in- 
corporation of [3H]thymidine in the presence of IGF-I, IGF-II, 
and insulin (Figure 1). The proliferation rate at saturating 
concentrations of these growth factors is similar to the 
extent of proliferation observed previously in cultures with 
serum-supplemented medium (Ernsberger et al., 1989b). 
The concentration that promoted half-maximal DNA syn- 
thesis was 5 x 10 -9 M for human IGF-I (hlGF-I) and 2 x 
10 -9 M for chick IGF-I (clGF-I; data not shown). Interest- 
ingly, hlGF-II was observed to be more active on sympa- 
thetic neurons (EDs9 of about 2 x 10 -9 M) than hlGF-I. 
The action of IGFs is modulated by IGF binding proteins 
(IGFBPs), which have a higher affinity to IGFs than IGF 
receptors (Cohick and Clemmons, 1993). To exclude the 
potential influence of IGFBPs on the determination of IGF 
potencies, a variant of IGF-I (tlGF-I) was tested that is not 
bound by IGFBPs. This truncated form of hlGF-I (tlGF-I), 
which differs from full-length IGF-I by the lack of the first 
three amino-terminal mino acids (Carlsson-Skwirut et al., 
1989), indeed displayed the highest biological activity 
(EDso of about 5 x 10 -l° M; Figure 1). Thus, this result 
suggests the presence of IGFBPs in these cultures that 
may interfere with IGF-I and IGF-II, but not with tlGF-I 
(Carlsson-Skwirut et al., 1989). The ECso for insulin- 
induced proliferation was about 4 x 10 -a M. Because insu- 
lin at high concentrations activates the IGF-I receptor 
(Sara and Hall, 1990), it seems likely that the effect of 
insulin is mediated through the IGF-I receptor. 
The effects of IGFs and insulin on sympathetic neuron 
proliferation are not only reflected by a stimulation of thy- 
midine incorporation, but also by an increase in cell num- 
ber (data not shown) that is similar to the increase in sym- 
pathetic neuron number in the serum-supplemented 
medium (Ernsberger et al., 1989b). As the sympathetic 
ganglion cell cultures consist of 95% neurons (Rohrer and 
Thoenen, 1987), it seems likely that IGFs and insulin act 
directly on sympathetic neurons. This assumption was 
confirmed using cultures devoid of nonneuronal cells. 
IGFs were found to stimulate proliferation in immunose- 
lected, pure neuronal cultures (99.8% Q211-positive neu- 
rons) to the same extent as in unselected cultures (data 
not shown). 
IGFs Stimulate Neurite Outgrowth 
After the period of neuronal proliferation, sympathetic neu- 
rons start to innervate their peripheral targets, and it 
seemed of interest to investigate the effect of IGFs on 
initial neurite extension since a stimulatory effect of IGFs 
on neurite outgrowth has been described previously for 
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Figure 2. Effects of hlGF-I, hlGF-II, and NGF on Neurite Outgrowth 
of Sympathetic Neurons 
(A) Sympathetic neurons were plated on laminin-coated culture dishes, 
and after 3 hr in culture the neurons were stained with the neuron- 
specific MAb Q211 to visualize the extent of neurite production. The 
proportion of neurite-bearing neurons was determined  about 400 
cells per variable and experiment. All factors were present in saturating 
concentrations. Data are expressed as the mean (+ SEM) of three 
independent experiments. Double asterisks indicate significant differ- 
ence from control (p < .005). 
(B) Sympathetic neurons were plated on fibronectin-coated culture 
dishes and analyzed after 20 hr in culture as described in (A). Data 
are expressed as the mean ( _ SEM) of five independent experiments. 
Triple asterisks indicate significant difference from control (p < .002).
postrnitotic sympathetic, sensory (Recio-Pinto et al., 
1986), and motor neurons (Caroni and Grandes, 1990). 
The effect of IGFs on the neurite outgrowth of sympa- 
thetic neurons was first analyzed on laminin, the substrate 
we routinely use for the culture of immature PNS neuron 
cultures. Neurite outgrowth was stimulated by IGFs, but 
not by NGF (Figure 2A). As the stimulatory effect of IGFs 
on laminin was relatively small, we also investigated their 
effect on a substrate, fibronectin, which stimulates neurite 
outgrowth to a much lesser extent than laminin (Erns- 
berger et al., 1989a). On fibronectin substrates, only a 
small proportion of the cells produced long neurites within 
the first day in culture. However, IGF-I and IGF-II elicited 
a large increase in the proportion of neurite-bearing cells 
(Figure 2B). The IGF-induced increase in the proportion 
of cells with long neurites may be explained by a selective 
proliferation of cells that are able to grow long processes, 
rather than by a direct effect of IGFs on neurite outgrowth. 
The former possibility was excluded, however, as the pro- 
p6rtio n of [3H]thymidine-labeled neurons with long neu- 
rites turned out not to be significantly different (59% _+ 
4% and 62% _ 4% for IGF-I and IGF-II, respectively) 
from the proportion of labeled cells with short neurites 
(61% -+ 6% and69e/o _ 6% for lGF-I and IGF-II, respec- 
tively). Thus, both on laminin and on fibronectin sub- 
strates, the IGFs stimulate the formation of neurites in 
immature sympathetic neurons. 
Expression of IGF-I and IGF-II mRNA 
in Sympathetic Ganglia 
Both IGF-I and IGF-II display distinct and different expres- 
sion patterns during embryonic development, suggesting 
a local autocrine or paracrine role in these tissues (Kikuchi 
et al., 1991; Rotwein et al., 1988; Bondy et al., 1990). In 
A 
~= o ~ 
c 
D ~ 
Figure 3. Quantitative Determination of IGF-I and IGF-II mRNA Con- 
tent in Sympathetic Ganglia and Cells 
Before RNA extraction, a defined amount ef exogenous IGF-I or IGF-II 
RNA standard (see Experimental Procedures) was added to the tis- 
sues. RNA was extracted, reverse transcribed, and amplified by PCR 
(27 cycles) using primers specific for either IGF-I or IGF-II. The prod- 
ucts were separated by gel electrophoresis, blotted, and visualized 
by hybridization with internal IGF-I- or IGF-II-specific oligonucleotide 
probes. In parallel, different concentrations of standard mRNAs were 
also amplified. 
(A) IGF-I determination; Southern blot of amplified products !rom E7 
sympathetic ganglia, E7 liver, and control without RNA and different 
concentrations of standard RNA (72, 36, 18, 9, 4.5, 2.3, and 1.1 fg). 
(B) IGF-II determination; same as in (A), but with IGF-II standards (300, 
150, 75, 37.5, 18.75, 9.3, 4.7, 2.3, and 1.1 fg) and probes. 
(C) IGF-I determiniation of E7 fibroblasts, neurons, and glial cells. 
(D) IGF-II determination of E7 fibroblasts and neurons. 
Open arrow, amplified exogenous standard RNA; closed arrow, ampli- 
fied endogenous RNA for IGF-I or IGF-II. 
this context, it was of interest to investigate whether IGFs 
are produced in sympathetic ganglia during the period of 
neurogenesis. 
To detect and quantitate the amount of IGF-I and IGF-II 
mRNA in the developing chick sympathetic ganglia, a sen- 
sitive PCR-based detection method was used (see Experi- 
mental Procedures). We could detect IGF-I and IGF-II 
rnRNA in E7 chick sympathetic ganglia, but only IGF-II 
mRNA was observed in the liver at that stage of develop- 
ment (Figures 3A and 3B). IGF-II mRNA is expressed in 
E7 sympathetic ganglia at higher levels than IGF-I, and 
as expected from previous studies in mammalian embryos 
(Sara and Hall, 1990), large amounts of IGF-II mRNA were 
found in E7 liver (Table 1). 
To identify the cellular source of IGFs in E7 sympathetic 
ganglia, the different cell types present were immunose- 
lected using cell type-specific antibodies that recognize 
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Table 1. IGF-I and IGF-II mRNA Content of Different Tissues 
and Cells 
IGF-I mRNA IGP-II mRNA 
Tissue Cells (fg/~g RNA) (fg/l~g RNA) 
E7 sympathetic ganglia 14 ± 3 31 ± 4 
Glial cells (04 +) Not detectable a <1 b 
Neurons (Q211÷) Not detectable a 40 ± 6 
Fibroblasts 6.8 ± 0.5 79 ± 9 
E7 liver Not detectable a 140 ± 16 
IGF-I and IGF-II mRNA levels in different issues and cells were deter- 
mined by quantitative PCR and Southern blots as described in Experi- 
mental Procedures. Data are mean ± SEM of three independent ex- 
periments. 
a IGF-I mRNA was not detected after 40 cycles. 
b IGF-II mRNA detectable after 40 cycles. 
cell surface antigens (Rohrer et al., 1985). The ganglia 
contain at that stage of development a very high proportion 
of neurons (95o)  that can be identified by the antibody 
Q211, as well as about 2% glial cells, recognized by the 
monoclonal antibody (MAb) 04,  and about 3% fibroblasts 
(Rohrer and Thoenen, 1987). The fibroblast population, 
defined by the absence of glial and neuronal markers and 
by the expression of fibronectin (Rohrer, 1985), is ex- 
pected to include endothelial cells and endoneurial fi- 
broblasts. Immunoselection for Q211 or 04 antigen- 
expressing cells resulted in pure neuronal and glial cell 
populations. Fibroblasts were selected by elimination of 
Q211- and O4-positive cells using complement-mediated 
cell lysis (Rohrer et al., 1985). Interestingly, IGF-I mRNA 
was detectable only in fibroblasts (Figure 3C). The neu- 
ronal and glial cells were negative for IGF-I mRNA even 
after 40 PCR cycles. In contrast, IGF-II mRNA was found 
in neurons and fibroblasts (Figure 3D) and, at very low 
levels, in glial cells (detectable after 40 PCR cycles). The 
levels of IGF-II mRNA in dissociated cells correspond to 
the amount of IGF-II found in intact ganglia (Table 1), as 
neurons account for 95% of the ganglion cells. In contrast, 
the amount of IGF-I mRNA in fibroblasts was much lower 
than expected from the observation that fibroblast IGF-I 
mRNA accounts for all the IGF-I mRNA in the ganglion. 
This discrepancy may be explained by a preferential oss 
of fibroblasts during the dissociation of the ganglia or by 
degradation of IGF-I mRNA. These results indicate that 
E7 sympathetic ganglion cells may have access to IGFs 
produced locally in the ganglion, and that IGF-II, owing to 
the higher mRNA expression level and a possible auto- 
crine action, may be more relevant for sympathetic neuron 
proliferation than IGF-I. In addition, the possibility has to 
be considered that IGF-II may also reach the ganglion as 
a systemic endocrine factor derived from the liver. 
To investigate whether the expression of IG Fs correlates 
with the extent of proliferation, we also analyzed a later 
stage of development (E12), when neuron proliferation in 
sympathetic ganglia is decreased (Rothman et al., 1978). 
We observed that the levels of IGF-I mRNA remained con- 
stant during this period (15 _+ 1.8 fg of IGF-I mRNA per 
microgram of RNA at E12), and the IGF-II mRNA levels 
increased about 5-fold to 161 + 17 fg of IGF-II mRNA per 
microgram of RNA at E12. The lack of correlation between 
Table 2. Effect of IGF-I Injections on Neuron Proliferation in 
Chick and Quail Lumbosacral Sympathetic Ganglia 
[3H]thymidine'Labeled Neur°ns(°/°) Increase 
Control IGF-I (%) 
E6 quail 22.15 _+ 1 29.5 - 0.75 b 33 
(n = 4) (n = 4) 
E6 quail 24 34 42 
(n = 1) (n = 1) 
E7 chick 18.8 + 1.15 25.65 _+ 1.05 a 36 
(n = 4) (n = 4) 
The first group of quail embryos (first line) was injected with IGF-I (0.1 
I~g) at E4 and E5. [3H]thymidine was applied at E6, and after 3 hr 
ganglia were dissected, dissociated, and analyzed for the proportion 
of [3H]thymidine-labeled cells. The second group of quail embryos 
(second line) was treated with IGF-I at E5 and E6. Chick embryos were 
injected with tlGF-I (0.1 ~g) at E5, E6, and E7; [3H]thymidine injection 
and analysis were carried out at E7. Data are expressed as mean _+ 
SEM of four independent experiments. 
a Significantly different from controls (p < .005). 
b Significantly different from controls (p < .0005). 
the time course of neuron proliferation and expression of 
IGFs suggests additional functions of the IGFs in sympa- 
thetic ganglion development, such as proliferation of glial 
cells, neurite outgrowth, and neuron survival. 
IGF-I Stimulates Sympathetic Neuron Proliferation 
In Vivo 
The effects of IGF-I observed in vitro suggest a function 
of IGF-t for two important steps of normal development of 
sympathetic neurons, proliferation and neurite outgrowth. 
To support the proposed action of IGFs, we studied the 
effects of IGF-I on sympathetic neuron proliferation in vivo. 
The avian embryo is well suited to analyze the effects of 
biologically active substances during development, since 
factors applied to the chorioallantoic membrane are deliv- 
ered to the embryo. Quail embryos were used for the first 
series of experiments, as it seemed likely that less factor 
would be required than for chick embryos, owing to the 
considerably smaller size of quail eggs. IGF-I was applied 
on days 4, 5, and 6, and thymidine incorporation was ana- 
lyzed at day 6 (Table 2). In a second series, tlGF-I was 
applied onto the chorioallantoic membrane of chick em- 
bryos at days 5, 6, and 7, and thymidine incorporation 
was analyzed later on day 7. Both experiments indicate 
a significant increase in sympathetic neuron proliferation 
upon addition of IGF-I (Table 2). Obviously, the extent of 
stimulation by exogenous application of factors depends 
on the proliferation status of the cells, controlled by endog- 
enous growth factors. The present result thus indicates 
that sympathetic neuron proliferation is not maximally 
stimulated in vivo and can be modulated by extrinsic con- 
trol both in vitro and in vivo. 
Anti-IGF-I Antibodies Diminish Proliferation and 
Neuron Number in Sympathetic Ganglia 
After demonstrating effects of IGFs on sympatheticneuron 
proliferation in vitro and in vivo, we tried to support the 
proposed role of IGFs for sympathetic neuron develop- 
IGFs Control Neuron Proliferation 
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Table 3. Effect of Neutralizing Anti-IGF-I Antibodies on 
Sympathetic Neuron Proliferation 
[3H]thymidine Incorporation 
(% of labeled neurons) 
Control 55 ± 4 (n = 4)(1000/0) 
Anti-IGF-I 42 ± 4 a (n = 4)(76%) 
Quail embryos were treated with antibody-producing hybridoma cells, 
and the proportion of thymidine-labeled neurons was determined at 
E6 as described in Experimental Procedures, 
p < .005 
ment by interfering with their action in vivo, using the neu- 
tralizing MAb sin1.2 raised against hlGF-I. 
The ability of this antibody to neutralize the biological 
effects of different IGFs was first assayed in vitro. The 
antibody crossreacts with hIGF-I, clGF-I, and, to a lesser 
extent, hlGF-II. To obtain a 10-fold reduction of the prolifer- 
ative effect of 50 ng/ml clGF-I or hlGF-I (7 x 10 -9 M), an 
antibody concentration of 5 i~g/ml is needed. The neutral- 
ization of 50 ng/ml hlGF-II required considerably higher 
antibody concentrations (20 ~g/ml). The degree of cross- 
reactivity of the antibody to clGF-II is not known. As de- 
scribed previously (Russell et al., 1984), the antibody did 
not antagonize the effect of insulin. To obtain sufficiently 
high antibody titers in the embryo, the antibody-producing 
hybridoma cells were applied onto the chorioallantoic 
membrane of 3- to 4-day-old quail embryos (Rohrer et al., 
1988). The antibody concentration was determined in 
brain homogenates and amounted to 5-12 I~g/g tissue for 
both control and anti-IGF-I antibodies. 
The effect of antibody treatment on sympathetic gan- 
glion proliferation was monitored by in vivo [3H]thymidine 
labeling at E6. We observed a 24% reduction in the propor- 
tion of [3H]thymidine-labeled sympathetic neurons in anti- 
IGF-I-treated embryos compared with controls (Table 3). 
The same reduction (24% _+ 8%; p < .025) was observed 
when anti-IGF-I-treated embryos and anti-glycine-recep- 
tor-treated embryos were compared. 
Antibody treatment resulted also in a reduction in the 
number of sympathetic neurons. Neuron numbers were 
determined in sections of E9 lumbosacral sympathetic 
ganglia (L3/4) from quail embryos that were grown without 
antibodies, with an unrelated antibody or with anti-IGF-I 
antibody sin1.2. The neuron number was found to be re- 
duced by about 20% compared with both controls (Table 
4). Thus, elimination of endogenous IGFs by neutralizing 
antibodies reduces sympathetic neuron proliferation and 
neuron number. These findings clearly demonstrate that 
IGFs are important for sympathetic neuron development. 
Discuss ion  
Growth factors, and in particular IGFs, have been impli- 
cated in the control of neurogenesis and neuron differenti- 
ation (Rohrer, 1990). The present study investigated the 
effects of IGF-I and IGF-II on chick sympathetic neuron 
proliferation and neurite outgrowth. We demonstrate that 
proliferation of chick sympathetic neurons is stimulated 
Table 4. Effect of Neutralizing Anti-IGF-I Antibodies on 
Neuron Number in Sympathetic Ganglia 
Neuron Number 
(% of control) 
Control 6367 _ 393 (100%) 
(19) 
Anti-IGF-I 5186 _ 341 a (81%) 
(15) 
Anti-GlyR 6566 ± 264 (103%) 
(5) 
Quail embryos were treated with hybridoma cells as described in Ex- 
perimental Procedures, and neuron number was determined insec- 
tions from E9 quail embryos (lumbar segment L3/4). Data are ex- 
pressed as mean - SEM (19, 15, and 5 embryos were analyzed as 
indicated). 
p < .05. 
by IGFs both in vitro and in vivo, and that IGF-I and IGF-II 
mRNA is expressed in the ganglion at the time of neuronal 
proliferation. We also show a neurite-promoting effect of 
IGFs for sympathetic neurons at an early stage of develop- 
ment, when very few cells respond to NGF. A function of 
endogenous IG Fs for normal sympathetic neuron develop- 
ment was demonstrated by the application of anti-IGF-I 
antibodies that resulted in a reduction of proliferation and 
neuron number in sympathetic ganglia. 
Chick sympathetic neurons were shown previously to 
survive and proliferate in vitro in serum-containing me- 
dium (Rohrer and Thoenen, 1987; Ernsberger et al., 
1989b). We now demonstrate that under serum-free condi- 
tions all chick sympathetic neurons survive for a culture 
period of 3 days, but are arrested in their proliferation. 
These conditions were used to test growth factors for their 
ability to stimulate sympathetic neuron proliferation. We 
found that neuronal proliferation, reflected by an increased 
proportion of [3H]thymidine-labeled neurons and by an in- 
crease in neuron number, was resumed after addition of 
IGFs or insulin, and we provided evidence that these ef- 
fects are due to a direct action of IGFs and insulin on 
sympathetic neurons. 
To stimulate neuronal proliferation, much higher con- 
centrations of insulin were needed as compared with IGF-I 
and IGF-II. IGF-I and IGF-II activate the IGF-I receptor at 
nanomolar concentrations. At about 100-fold higher con- 
centrations, they are also known to bind to and elicit biolog- 
ical effects at the insulin receptor (Sara and Hall, 1990). 
Conversely, insulin is able to activate the heterologous 
IGF-I receptor at high concentrations. The present data 
thus suggest that the effects of insulin are mediated 
through the IGF-I receptor and that the IGF-I receptor and 
its ligands are involved in the control of neuronal prolifera- 
tion. It should be noted, however, that hlGF-II, which is 
10-fold less potent than hlGF-I on cells expressing hlGF-I 
receptors (Germain-Lee t al., 1992), was more active than 
hlGF-I on chick sympathetic neurons. This may be due 
either to previously described untypical properties of the 
avian IGF-I receptor (Duclos and Goddard, 1990) or to the 
presence of another receptor (XR) that has been impli- 
cated in the action of IGF-II (Baker et al., 1993). An involve- 
ment of the mannose 6-phosphate receptor/IGF-II recep- 
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tor is excluded, as the avian receptor lacks the IGF-II 
binding site (Clairmont and Czech, 1989). It was observed 
previously that truncated IGF-I, which is an IGF-I variant 
lacking the first three amino acids at the amino terminal, 
was more active than full-length IGF-I (Carlsson-Skwirut 
et al., 1989). IGF-I and tlGF-I do not differ significantly in 
their affinity to the IGF-I receptor (Ballard et al., 1986; 
Carlsson-Skwirut et al., 1989). The difference in their bio- 
logical activity is due to a difference in interaction with 
IGFBPs. Whereas IGFBPs bind to normal IGF-I and IGF-II 
and prevent their interaction with the receptor, they are 
much less potent inhibiting the action of tlGF-I (Carlsson- 
Skwirut et al., 1989). IGFBPs were first discovered in se- 
rum and were considered as the carrier proteins for endo- 
crine IGF-I produced in the liver, but were later found to be 
produced in many tissues (Cohick and Clemmons, 1993). 
Our finding that tlGF-I is more active than hlGF-I or IGF-II 
suggests that IG FBP(s) is also present in sym pathetic neu- 
ron cultures and, by partly neutralizing IGF-I and IGF-II, 
may account for the lower specific activity of these agents 
compared with tlGF-I. 
A complex picture is obtained when studies on effects 
of different growth factors on neuronal precursor cells from 
various parts of the nervous system are compared (Gao 
et al., 1991; DiCicco-Bloom et al., 1990; Anchan et al., 
1991; Lillien and Cepko, 1992; Drago et al., 1991). The 
results suggest that proliferation of neuronal precursor 
cells in different parts of the nervous system may bede- 
pendent on the presence of different factors or on a differ- 
ent combination of factors. This would be analogous to 
the situation in the hematopoietic system, where progeni- 
tor cells that are committed to different cell lineages de- 
pend on different growth factors (Metcalf, 1991). An addi- 
tional explanation for different growth factor responses 
observed for different precursor cell cultures is that cells 
may change their growth factor requirements during matu- 
ration (Metcatf, 1991). There is indeed strong evidence 
that neurons and glial cells change their requirements for 
growth factors (Lillien and Cepko, 1992; Barres et al., 
1993) and survival factors (DiCicco-Bloom et al., 1993; 
Birren et al., 1993) during development. On the other hand, 
it is very striking that, whenever investigated, effects of 
IGFs on neuron proliferation have been observed. This 
suggests that IGFs may be active in many neuronal lin- 
eages and interact with different factors, depending on 
the cell lineage. In cultures of neuroepithelial cells, it was 
observed that the proliferation effect of FGF is dependent 
on the expression and function of IGF-I (Drago et al., 1991). 
A similar observation was made for oligodendrocyte pre- 
cursor cells, for which a proliferation effect of neuro- 
trophin-3 was found to be dependent on IGF-I (Barres et 
al., 1993, 1994). There is, however, also evidence for inde- 
pendent action of two growth factors. Neurotrophin-3 was 
shown to act as a survival factor for rat sympathetic neu- 
rons, whereas IGFs or FGF seem to be responsible for 
cell proliferation (DiCicco-Bloom et al., 1993; Birren et al., 
1993). 
In the nervous system, IGFs are known to affect another 
important step in neuron development, the production of 
neurites. IGF-II and insulin have been shown to stimulate 
neurite outgrowth from chick sympathetic (E12) and sen- 
sory neurons (El0; Recio-Pinto et al., 1986). In E12 chick 
embryos, the majority of sympathetic neurons have inner- 
vated their peripheral target (Kirby et al,. 1978). Neurite 
outgrowth from postmitotic sympathetic neurons observed 
in these experiments thus represents the regeneration of 
axons that were lesioned during the dissection and disso- 
ciation of the ganglia. In contrast, the ganglion cells at 
E7 are proliferating, immature neurons, and the neudtes 
produced in vitro represent initial neurite outgrowth rather 
than regeneration. There is general agreement that the 
initial neurite outgrowth of sympathetic and sensory neu- 
rons occurs independently of NGF both in vitro and in 
vivo, whereas neurite outgrowth from mature neurons is 
strongly stimulated by NGF (Coughlin and Collins, 1985; 
Davies et al., 1987; Ernsberger and Rohrer, 1988; Erns- 
berger et al., 1989a). As factors involved in the initial, NGF- 
independent outgrowth of neurites to their target are un- 
known, it was of interest to investigate whether IGFs are 
also acting at this early stage. We found that initial neurite 
outgrowth is indeed stimulated by IGFs on both laminin 
and fibronectin. These in vitro observations suggest that 
initial outgrowth may be controlled by the presence of out- 
growth-promoting molecules of the extracellular matrix 
(Ernsberger et al., 1989a) and of soluble growth factors. 
Thus, it seems that IGFs are able to stimulate neurite pro- 
duction at all stages of development, from the initial neurite 
outgrowth to the sprouting (Caroni and Grandes, 1990) 
and regeneration (Kanje et al., 1989; Near et al., 1993; 
Glazner et al., 1993) of mature axons. 
The effects of IGFs on sympathetic neuron proliferation 
and neurite outgrowth observed in vitro lead to the ques- 
tion of whether IGFs are available to developing sym- 
pathoadrenal cells during neurogenesis. Both IGF-I and 
IG F-II are expressed during mammalian fetal development 
in many tissues (Sara and Hall, 1990; Cohick and Clem- 
mons, 1993), but the expression of IGF-I and IGF-II mRNA 
during early chick development is only poorly documented 
(Serrano et al., 1990; Kikuchi et al., 1991). Using a sensi- 
tive PCR-based detection method, we now demonstrate 
that both IGF-I and IGF-II mRNAs are expressed in E7 
sympathetic ganglia. The level of IGF-II mRNA expression 
is higher than that of IGF-I, and a major site of IGF-II ex- 
pression is the embryonic liver. These findings suggest 
that IGF-I and/or IGF-II, either produced in the ganglion 
or provided as endocrine growth factor from the liver, are 
available during neurogenesis in sympathetic ganglia. Us- 
ing immunoselection procedures to analyze IGF-I and IGF- 
II mRNA levels in defined ganglion cell populations, we 
observed that IGF-I mRNA is expressed by ganglion fibro- 
blasts, whereas IGF-II is expressed by neurons and fibro- 
blasts and, at low levels, by glial cells. The cellular localiza- 
tion of IGF-I and IGF-II mRNA is compatible with both 
paracrine and autocrine modes of action of IGFs on sym- 
pathetic neurons. In contrast o our results on chick sympa- 
thetic neurons, in situ hybridization studies on developing 
rat PNS could not detect a signal for IGF-I in sympathetic 
ganglia (Bondy et al., 1990), and IGF-II mRNA was de- 
tected in PNS ganglia only in endothelial cells lining blood 
vessels (Bondy et al., 1990; Ayer-Le Lievre et al., 1991). 
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The difference observed may be due to a species differ- 
ence, but a more likely explanation is the different sensitiv- 
ity of the methods used. Although the early expression 
of IGF-I and IGF-II in developing peripheral ganglia is in 
agreement with the proposed role of these growth factors 
in the control of neurogenesis, the expression of IGFs in- 
creases rather than decreases in the ganglion at the end 
of neurogenesis. This suggests a role for IGFs in later 
aspects of development (e.g., cell survival or neurite out- 
growth). In support of such a role, it should be mentioned 
that during regeneration, a process that often recapitu- 
lates developmental schemes, IGF-I and IGF-II mRNA ex- 
pression is up-regulated in peripheral nerves (Glazner et 
al., 1993, Soc. Neurosci., abstract). 
Evidence for a role of IGFs in neuron development has 
also been obtained in developing CNS by the analysis of 
the expression of IGF-I receptor and IGF-I mRNA. It was 
found that IGF-I receptor is expressed in all proliferative 
zones (Bondy et al., 1992), whereas IG F-I m RNA, analyzed 
by in situ hybridization, is undetectable in these regions 
(Bondy et al., 1992; Ayer-Le Lievre et al., 1991). These 
results argue against an autocrine effect of IGF-I but do 
not exclude paracrine effects of IGF-I produced by earlier 
differentiated neurons (Bartlett et al., 1991). In addition, 
as sensitive RNA blot analysis indicates the presence of 
IGF-I mRNA in El0 mouse brain neuroepithelium (Drago 
et al., 1991) and E14 rat brain (Rotwein et al., 1987), one 
may speculate that IGF-I is produced in proliferation zones 
at low levels that remain undetected by in situ hybridiza- 
tion. At: later stages, IGF-I mRNA was detected in early 
differentiating neurons (Bondy, 1991). This result sug- 
gests that IGF-I may play a role in neurite growth or synap- 
togenesis in the CNS. 
After establishing IGF mRNA expression during the pe- 
riod of neurogenesis, the role of IGF-I in sympathetic neu- 
ron proliferation was verified by the analysis of its in vivo 
action. Since IGF-I application also resulted in an in- 
creased number of thymidine-incorporating eurons in 
vivo, we conclude that the effects observed in vitro are of 
physiological relevance. It should be pointed out that the 
degree of stimulation obtainable in vivo by the addition of 
exogenous factors depends on the background levels 
of endogenous timulation. The observed in vivo effect of 
IGF-I thus demonstrates that sympathetic neuron prolifer- 
ation is not maximally stimulated in vivo. 
The importance of endogenous IGFs for sympathetic 
neuron development was further demonstrated by the ap- 
plication of neutralizing anti-IGF-I antibodies. We could 
show that both sympathetic neuron proliferation and neu- 
ron number were reduced in embryos treated with anti- 
IGF-I antibodies. The extent of the antibody's effect on 
thymidine incorporation was similar to the effect on neuron 
number. Thus, the most parsimonious interpretation ofthe 
results would be that the reduced neuron number would 
be the result of a decrease in proliferation. The number 
of sympathetic neurons in E9 ganglia is, however, deter- 
mined both by proliferation and by selective, neurotrophin- 
controlled survival. A reduced neuron production may en- 
able a larger proportion of the neurons generated to 
survive in response to the limited amounts of neurotro- 
phins. In addition, neurite outgrowth-promoting effects of 
IGFs are considered to be important o guarantee uptake 
of neurotrophins and subsequent neuronal survival. Thus, 
the relative contribution of effects of anti-IGF-I on neuron 
proliferation or survival remain to be determined. 
The limited effect of the antibody treatment could be 
due either to the fact that only subpopulations are respon- 
sive, to up-regulation of IGF-I production upon antibody 
treatment, to redundant control by other growth factors, or 
to the limited extent of IGF elimination. The last possibility 
seems not unlikely, as we observed a reduced cross- 
reactiv'ty between the antibody and IGF-II. The antibodies 
neutralize the in vitro effects of recombinant hlGF-I and 
clGF-I with high efficiency, but higher concentrations are 
required to prevent the action of hlGF-II. This raises the 
possibility that mature clGF-II, which is about 62% homol- 
ogous to clGF-I (Taylor and Brickell, personal communica- 
tion), may be recognized to an even lesser degree by the 
antibody. Further work will be needed to determine the 
relative importance of IGF-I and IGF-II. 
In conclusion, there is considerable vidence for effects 
of IGFs on sympathoadrenal cells throughout develop- 
ment. With respect to proliferation, we now have demon- 
strated that the cells respond in vivo in a similar way as 
in vitro. We also provided evidence indicating that endoge- 
nous IGFs are involved in normal development of sympa- 
thetic neurons. It is known that the final number of neurons 
generated is not due to a depletion of neuron precursors 
at the end of neurogenesis (Xue et al., 1985; Reynolds 
and Weiss, 1992). Rather, the cessation of neurogenesis 
may be due to reduced levels of growth factors, to reduced 
responsiveness to growth factors, or to negative feedback 
control by the newly generated neurons. As IGF mRNA 
production in sympathetic ganglia increases rather than 
decreases at the end of neurogenesis, a reduction in the 
levels of IGFs cannot account for the cessation of prolifera- 
tion. Our data suggest that IGFs are necessary for prolifer- 
ation and play a permissive rather than an instructive role. 
Although the mechanisms that determine the number of 
neurons in different ganglia of one species, or different 
neuron numbers in ganglia of different species (Purves, 
1988), are still far from being well understood, our data 




Recombinant hlGF-I, hiGF-II, and tlGF-I, which is commercially avail- 
able as brain IGF-I, were purchased from Boehringer Mannheim 
(Mannheim, Germany). Recombinant clGF-I was from GRO PEP (Ade- 
laide, Australia). Insulin (bovine, cell culture-tested), Putrescine, trans- 
ferrin, progesteron, selenium, heparin, and bovine serum albumin 
(BSA; A4161 or A7906) were from Sigma (Deisenhofen, Germany). 
NGF was prepared as described previously (Rohrer and Thoenen, 
1987). The MAb Q211 was a generous gift from S. Henke-Fahle, Auge- 
nklinik der Universit&t TL~bingen, T~Jbingen, Germany. The MAb 04 
was diluted from a concentrated hybridoma supernatant. The hybrid- 
oma cells producing anti-IGF-I antibodies (clone sin1.2; Russell et al., 
1984) were obtained from UBI (Lake Placid, New York). The hybridoma 
(sm t.2) was generated by immunizing mice with hlGF-I. The hybrid- 
oma cells producing anti-glycine r ceptor (mab2) were obtained from 
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Dr. A. Kirsch, Dept. Neurochernistry, MPI fLir Hirnforschung, Frankfurt, 
Germany. 
Cell Culture 
Lumbosacral sym pathetic hain ganglia were dissected from 7-day-old 
(E7) chick embryos, and neurons were prepared and cultured as de- 
scribed (Ernsberger et al., 1989a, 1989b). For serum-free cultures, we 
used Ham's F14 medium supplemented with putrescine (100 ~M), 
transferrin (5 ~.g/ml), progesteron (20 nM), and selenium (30 nM). Cell 
counts were obtained by examining phase-bright cells in randomly 
selected fields of the culture dish. Approximately 5% of the total sur- 
face of the dish was examined, and triplicates (three dishes) were 
counted for each parameter in each experiment. Effects of IGFs on 
neurite formation were assayed after a culture period of 3 or 24 hr in 
dishes coated with laminin or fibronectin, respectively, by determining 
the proportion of neurons with long processes (>/4 cell diameters) in 
cultures stained with the neuron-specific cell surface antibody Q211 
as described previously (Ernsberger and Rohrer, 1988; Ernsberger 
et al., 1989a). Data were analyzed for significant difference between 
controls and IGF-treated embryos using Student's t test with Bonferroni 
correction for multiple t tests. In some neurite growth experiments on 
fibronectin, [3H]thymidine was added at the time of plating, and after 
24 hr the cells were stained with MAb Q211, processed for autoradiog- 
raphy, and analyzed for the proportion of neurons with long or short 
processes that were [3H]thymidine-labeled. 
Pure neuronal or glial cells were prepared by irnmunoselection 
("panning") using the cell type-specific MAbs Q211 and 04 (Rohrer et 
al., 1985; Rohrer and Thoenen, 1987). Petridishes (100 mrn diameter; 
Greiner) were coated overnight with 10 rnl of 50 mM Tris-HCI buffer 
(pH 9.5) containing 5 ~g/ml rabbit anti-mouse IgM antibodies (Jackson 
Laboratories). After washing of the dishes with PBS (3 x), they were 
coated with 5 rnl of HEPES-buffered F14 medium containing MAb 
Q211 or 04 and 1 mg/ml BSA for 1 hr at room temperature. After 
washing of the dishes (3 x), about 1 x 10 ~ freshly dissociated cells 
from E7 sympathetic ganglia were added to the dishes for 45 min in 
the same medium. Nonattached cells were removed by washing with 
PBS (3 x). Attached cells were harvested by trypsinization and col- 
lected by centrifugation. Aliquots of the cells were replated and ana- 
lyzed after 1 day in culture for the proportion of fibroblasts (Q211- and 
O4-negative), glial cells (O4-positive), and neurons (Q211-positive). 
The panning procedure resulted in pure neuronal populations (99.8% 
± 0.20/0 Q221-positive [n = 3]) and populations strongly enriched 
for glial cells (960/0 ± 1.7% O4-positive [n = 3]). The selection for 
fibroblasts using complement-mediated cell lysis of Q211- and 04- 
positive cells (Rohrer et al., 1985) resulted in populations virtually de- 
void of neurons and glial cells (99.7% ± 0.2% of the cells lacking 
both Q211 and 04 antigens; n = 3). 
Sympathetic neuron proliferation was analyzed in vitro by adding 
methyl-[3H]thymidine (40-60 Ci/mmol; 1 p.Ci/rnl; Amersham, Braun- 
schweig, Germany ) after 1 day in culture for 18-24 h r and processing 
for autoradiography as described previously (Ernsberger etal., 1989b; 
Rohrer and Thoenen, 1987). The proportion of [3H]thymidine-labeled 
neurons was determined by analyzing 300 neurons per dish. Tripli- 
cates were counted for each data point. 
Analysis of In Vivo Effects of IGF-I 
Quail and chick eggs were incubated, and a window was made in the 
shell overlying the vascularized chorioallantoic membrane (CAM) on 
E3 (quail) or E4 (chick). hlGF-I was dissolved in PBS/glucose (4 mg/ 
ml), and 25 ~1 of this solution (containing 0.1 ~g of hlGF-I) was applied 
daily to the CAM. Control embryos were treated with PBS/glucose. 
Quail embryos were treated at days 4 and 5, in one case at days 5 
and 6. Chick embryos were treated at days 5, 6, and 7. At E6 (quail) 
or E7 (chick), 20 ~Ci of [3H]thymidine was applied in a volume of 50 
I~1 of PBS onto the CAM. After a 3 hr thymidine pulse, the ganglia were 
dissected, dissociated to single cells, and plated onto polyornithine/ 
laminin-coated dishes. Ganglia from 5-8 embryos were pooled for 
each experiment. Cells were allowed to attach to the culture dish for 
3 hr, stained with MAb Q211, and processed for autoradiography. The 
proportion of cells that were both Q211-positive and [3H]thymidine- 
labeled was determined. Data were analyzed for significant difference 
between controls and IGF-I-treated embryos using Student's t test. 
Antibody Treatment 
The treatment of embryos with anti-IGF-I antibodies involves the 
growth of hybridoma cells in the egg as decribed previously (Rohrer 
et al., 1988). At E3 or E4, 2 x 106 hybridoma cells secreting anti-IGF-I 
antibodies (clone sm 1.2; Russell et al., 1984) or hybridoma cells secre- 
ting anti-glycine receptor antibodies (clone mab2; Pfeiffer et al., 1984) 
were applied onto the the CAM in 50 I~1 of PBS (pH 7.3). Experiments 
that were analyzed for neuron number received hybridoma cells at 
E3. After this morphological analysis was terminated, we observed 
that somewhat higher antibody titers are obtained at E7 when the 
hybridoma cells are applied at E4 rather than at E3; these conditions 
were used to investigate the effects of anti-IGF-I antibodies on sympa- 
thetic neuron proliferation. 
Determination of Mouse Antibody Levels in Quail Tissues 
The levels of anti-IGF-I antibody were determined in brain tissue using 
an enzyme imrnunoassay (enzyme-linked irnmunosorbent assay 
[ELISA]) for IGF-I. The brains were carefully dissected (without menin- 
ges), washed, and homogenized in 80 mM NaCI, 5 mM phosphate 
buffer (pH 7.4), supplemented with protease inhibitors phenylmethyl- 
sulfonyl fluoride (0.1 mM), leupeptin (0.1 M), benzamidin (1 mM), and 
aprotinin (20 KIU/ml). The soluble fraction was obtained by centrifuga- 
tion. clGF-I was bound to 96-well plates, and supernatants of the tissue 
samples, diluted in PBS/0.1% Tween-20, were added to the plate. 
Bound anti-IGF-I antibody was detected using horseradish peroxi- 
dase-coupled anti-mouse irnrnunoglobulin and ABTS as substrate 
(Amersharn). A standard curve was constructed using known quanti- 
ties of purified anti-IGF-I antibody (UBI). This assay measures the 
levels of biologically active antibodies that are able to interact with 
clGF-I. Alternatively, the levels of anti-IGF-I antibody and anti-glycine 
receptor antibody were determined by a two-site ELISA using affinity- 
purified anti-mouse IgG antibodies to coat the 96-well dishes. The 
levels of anti-IGF-I antibodies detected by both procedures were virtu- 
ally identical. 
Analysis of In Vivo Effects Of Anti-IGF-I Antibody 
For the analysis of neuronal proliferation, quail embryos were treated 
with hybridoma cells or PBS, and then 20 p.Ci of [3H]thymidine was 
applied to the CAM. After about 8 hr, the ganglia were dissected, 
dissociated to single cells, and plated on polyornithine/laminin-coated 
dishes. After plating, the proportion of [3H]thymidine-labeled cells was 
determined as previously described (Rohrer and Thoenen, 1987). Gan- 
glia from different embryos were analyzed separately. Statistical signif- 
icance was determined using unpaired Student's t test. 
For histological analysis of sympathetic neuron number, embryos 
were fixed at E9 in Bouin's fixative, embedded in paraffin, and sec- 
tioned at 6 p_m. Sections were stained either with hematoxylin and 
eosin or with thionin. Neurons were counted in every fifth section 
through L3 or L4 sympathetic ganglion. As described previously (Op- 
penheim et al., 1989), only large to moderate sized cells containing 
substantial cytoplasm and a distinct nucleus and nucleolus were in- 
cluded in the cell counts. The size of cells included in the cell counts 
was based on average nuclear (not soma) diameter of 4-6 ~.m. In this 
way, inclusion of nonneuronal cells and double counting of neurons 
were effectively eliminated. All cell counts were done blind as to the 
treatment conditions of the embryos being examined. Statistical signifi- 
cance was determined using unpaired Student's t test with Bonferroni 
correction for multiple t tests. 
Construction of IGF-I and IGF-II Plasmids with 
Oligonucleotide Inserts 
For construction of a plasmid that allows production of exogenous 
"standard" IGF-I mRNA, the clGF-I cDNA (pGEM3Z; gift of Dr. Rotwein; 
Kajimoto and Rotwein, 1989) was subcloned into pBluescript (pKS-; 
Stratagene, Heidelberg, Germany). The cDNA was cut at position 550 
with Saul, and a 53 bp oligonucleotide was inserted. For construction 
of IGF-II plasmids containing an insertion in the region to be amplified, 
a clGF-II cDNA plasmid (pBS SK+; gift of Dr. Brickell, UCL, London) 
was used. After deletion of the Sacll restriction site in the polylinker 
region, Deal was used to cut the cDNA at position 342, and a 57 bp 
oligonucleotide was inserted. The correct insertion of both oligonucleo- 
tides was confirmed by sequencing. The standards were prepared 
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using T3 RNA polymerase, and concentrations were determined spec- 
trophotometrically. 
PCR 
Total cellular RNA was prepared from E7 sympathetic ganglia and 
from immunoselected cells according to Chomczynski and Sacchi 
(1987). The selected cells were pelleted and directly lysed in the guan- 
idinium isothiocyanate solution. Defined amounts of an exogenous 
IGF-I or IGF-II mRNA standard were added to the tissue samples be- 
fore RNA extraction. The amount of exogenous standard to be added 
to the samples was determined empirically for each tissue so that 
exogenous and endogenous RNA were present in amounts repre- 
sented in the standard curve and in roughly equivalent amounts. After 
reverse transcription and amplification of both endogenous and exoge- 
nous IGF mRNAs using identical PCR primers, two products were 
obtained, a larger standard and a smaller band, resulting from the 
amplification of endogenous IGF mRNA. The products were identified 
by hybridization with a specific internal oligonucleotide probe. By the 
parallel amplification of defined amounts of standard IGF-I or IGF-II 
mRNA, the levels of endogenous IGF mRNAs could be determined. 
Tissues negative for PCR products after 27 cycles were re-analyzed 
in the absence of exogenous standard at 40 cycles. 
IGF.I 
Endogenous IGF-I and exogenous standard mRNA for IGF-I were re- 
verse transcribed and amplified using the same pair of primers. The 
upstream primer 1 (GCTGAGCTGGTTGATGCTCTT) corresponds to 
positions 412-432 of mature IGF-I, and the 3' primer 2 (ACCTCTACAT- 
GACACGAGGTTATTT) corresponds to positions 560-584 (Kajimoto 
and Rotwein, 1989). The region amplified encloses an intron-exon 
border (Kajimoto and Rotwein, 1991). The amplification results in 226 
and 173 bp cDNA fragments for the standard and endogenous IGF-I 
cDNA, respectively. No amplification product was observed with geno- 
mic DNA or IGF-II cDNA or in the absence of IGF-I mRNA. Total RNA 
was used for cDNA synthesis by AMV reverse transcriptase (10 U; 
Life Sciences, St. Petersburg, Florida) using primer 2 of the PCR. 
First-strand synthesis was carried out at 42°C for 60 min in 50 Ill using 
the First Strand Synthesis Kit (Stratagene), and 10 i11 of the single 
strand cDNA reaction mixture was used for the PCR reaction con- 
taining the following components: 5 ILl of 10 x TaqBuffer (1 x TaqBuf- 
fer is 10 mM Tris-HCI [pH 8.3], 50 mM KCI, 1.5 mM MgCI2, 0.001% 
gelatine), 2 p_l of dNTPs (each 5 mM), primer 1 and primer 2 (each 600 
ng), 0.5 p.I (5 U/I~I) of TaqPol (AmpliTaq polymerase from Perkin-Elmer; 
0berlingen, Germany), and water to a final volume of 50 p,l. PCR 
reaction was started by"hot start" (94°C; 1 min), carried out (27 cycles) 
in a Perkin-Elmer temperature cycler at 94°C for 1 min, 62°C for 1.5 
min, and 72°C for 1.5 min each cycle, and terminated with 5 rain 
at 72°C. 
For quantitation, different amounts of IGF-I cDNA were amplified 
in parallel. Aliquots of the PCR products were applied to a 2.3% aga- 
rose gel containing ethidium bromide. Following electrophoresis the 
DNA was blotted to nylon membrane (Hybond N+; Amersham), and 
the blots were hybridized with an internal 32P-labeled clGF-I oligonucle- 
otide probe (positions 490-513 of IGF-I cDNA; 5-8 x 108 cpm/ml; 
9 x 108 cpm/p,g). After autoradiography the film was densitometrically 
scanned, and the values for endogenous mRNA were corrected ac- 
cording to the recovery of the exogenous standard. The levels of IGF-I 
and IGF-II mRNA are expressed as femtograms of mRNA per micro- 
gram of total RNA. 
IGF-II 
For reverse transcription and PCR of endogenous IGF-il and exoge- 
nous standard mRNA for IGF-II, the same pair of primers was used. 
The 21 bp upstream primer 1 (AGACCAGTGGGGACGAAATAAC) cor- 
responds to positions 310-330 of mature IGF-II, and the 26 bp 3'primer 
2 (GGACGCACGGGCAGCCATGGCCACCG) corresponds to posi- 
tions 633-658 (Taylor et al., 1991; Taylor and Brickell, unpublished 
data). The region amplified encloses an intron-exon border. The ampli- 
fication results in a 405 bp product for the standard and a 348 bp 
product for endogenous IGF-II. The reverse transcription was per- 
formed as described for IGF-I, and for PCR the same components 
were used. PCR reactions were started by "hot start," carried out (27 
cycles) at 94°C, 65°C, and 72°C for 1 rain each cycle, and terminated 
with 5 min at 72°C. No product was obtained without template and 
with IGF-I cDNA. For hybridization, an internal 32P-labeled clGF-II oligo- 
nucleotide probe corresponding to positions 415-438 of the mature 
peptide was used. Conditions for hybridization and washing proce- 
dures were identical to those used for IGF-I blots. 
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